125 related articles for article (PubMed ID: 35675857)
1. HOXA1, a breast cancer oncogene.
Belpaire M; Taminiau A; Geerts D; Rezsohazy R
Biochim Biophys Acta Rev Cancer; 2022 Jul; 1877(4):188747. PubMed ID: 35675857
[TBL] [Abstract][Full Text] [Related]
2. The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells.
Hou L; Xu B; Mohankumar KM; Goffin V; Perry JK; Lobie PE; Liu DX
Int J Oncol; 2012 Dec; 41(6):2285-95. PubMed ID: 23064471
[TBL] [Abstract][Full Text] [Related]
3. HOXA1 binds RBCK1/HOIL-1 and TRAF2 and modulates the TNF/NF-κB pathway in a transcription-independent manner.
Taminiau A; Draime A; Tys J; Lambert B; Vandeputte J; Nguyen N; Renard P; Geerts D; Rezsöhazy R
Nucleic Acids Res; 2016 Sep; 44(15):7331-49. PubMed ID: 27382069
[TBL] [Abstract][Full Text] [Related]
4. The Pbx interaction motif of Hoxa1 is essential for its oncogenic activity.
Delval S; Taminiau A; Lamy J; Lallemand C; Gilles C; Noël A; Rezsohazy R
PLoS One; 2011; 6(9):e25247. PubMed ID: 21957483
[TBL] [Abstract][Full Text] [Related]
5. HOXA1-stimulated oncogenicity is mediated by selective upregulation of components of the p44/42 MAP kinase pathway in human mammary carcinoma cells.
Mohankumar KM; Xu XQ; Zhu T; Kannan N; Miller LD; Liu ET; Gluckman PD; Sukumar S; Emerald BS; Lobie PE
Oncogene; 2007 Jun; 26(27):3998-4008. PubMed ID: 17213808
[TBL] [Abstract][Full Text] [Related]
6. Detection of HOXA1 expression in human breast cancer.
Chariot A; Castronovo V
Biochem Biophys Res Commun; 1996 May; 222(2):292-7. PubMed ID: 8670198
[TBL] [Abstract][Full Text] [Related]
7. HOXA1 is required for E-cadherin-dependent anchorage-independent survival of human mammary carcinoma cells.
Zhang X; Emerald BS; Mukhina S; Mohankumar KM; Kraemer A; Yap AS; Gluckman PD; Lee KO; Lobie PE
J Biol Chem; 2006 Mar; 281(10):6471-81. PubMed ID: 16373333
[TBL] [Abstract][Full Text] [Related]
8. Hoxa1 targets signaling pathways during neural differentiation of ES cells and mouse embryogenesis.
De Kumar B; Parker HJ; Paulson A; Parrish ME; Zeitlinger J; Krumlauf R
Dev Biol; 2017 Dec; 432(1):151-164. PubMed ID: 28982536
[TBL] [Abstract][Full Text] [Related]
9. Differences in gene expression between wild type and Hoxa1 knockout embryonic stem cells after retinoic acid treatment or leukemia inhibitory factor (LIF) removal.
Martinez-Ceballos E; Chambon P; Gudas LJ
J Biol Chem; 2005 Apr; 280(16):16484-98. PubMed ID: 15722554
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional activation of signal transducer and activator of transcription (STAT) 3 and STAT5B partially mediate homeobox A1-stimulated oncogenic transformation of the immortalized human mammary epithelial cell.
Mohankumar KM; Perry JK; Kannan N; Kohno K; Gluckman PD; Emerald BS; Lobie PE
Endocrinology; 2008 May; 149(5):2219-29. PubMed ID: 18276758
[TBL] [Abstract][Full Text] [Related]
11. Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene.
Zhang X; Zhu T; Chen Y; Mertani HC; Lee KO; Lobie PE
J Biol Chem; 2003 Feb; 278(9):7580-90. PubMed ID: 12482855
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells.
Wang X; Li Y; Qi W; Zhang N; Sun M; Huo Q; Cai C; Lv S; Yang Q
Oncotarget; 2015 Oct; 6(32):32737-47. PubMed ID: 26417931
[TBL] [Abstract][Full Text] [Related]
13. CircRASSF2 acts as a prognostic factor and promotes breast cancer progression by modulating miR-1205/HOXA1 axis.
Zhong W; Bao L; Yuan Y; Meng Y
Bioengineered; 2021 Dec; 12(1):3014-3028. PubMed ID: 34180753
[TBL] [Abstract][Full Text] [Related]
14. HOXA1 Is an Antagonist of ERα in Breast Cancer.
Belpaire M; Ewbank B; Taminiau A; Bridoux L; Deneyer N; Marchese D; Lima-Mendez G; Baurain JF; Geerts D; Rezsohazy R
Front Oncol; 2021; 11():609521. PubMed ID: 34490074
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of HOXA1 promotes tumorigenesis and development of non‑small cell lung cancer: A comprehensive investigation based on reverse transcription-quantitative polymerase chain reaction and bioinformatics analysis.
Zhang Y; Li XJ; He RQ; Wang X; Zhang TT; Qin Y; Zhang R; Deng Y; Wang HL; Luo DZ; Chen G
Int J Oncol; 2018 Jul; 53(1):73-86. PubMed ID: 29658571
[TBL] [Abstract][Full Text] [Related]
16. HOXA1 drives melanoma tumor growth and metastasis and elicits an invasion gene expression signature that prognosticates clinical outcome.
Wardwell-Ozgo J; Dogruluk T; Gifford A; Zhang Y; Heffernan TP; van Doorn R; Creighton CJ; Chin L; Scott KL
Oncogene; 2014 Feb; 33(8):1017-26. PubMed ID: 23435427
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA SNHG1 activates HOXA1 expression via sponging miR-193a-5p in breast cancer progression.
Li J; Zeng T; Li W; Wu H; Sun C; Yang F; Yang M; Fu Z; Yin Y
Aging (Albany NY); 2020 Jun; 12(11):10223-10234. PubMed ID: 32497022
[TBL] [Abstract][Full Text] [Related]
18. HOXA1 is overexpressed in oral squamous cell carcinomas and its expression is correlated with poor prognosis.
Bitu CC; Destro MF; Carrera M; da Silva SD; Graner E; Kowalski LP; Soares FA; Coletta RD
BMC Cancer; 2012 Apr; 12():146. PubMed ID: 22498108
[TBL] [Abstract][Full Text] [Related]
19. PRDM14, a putative histone methyl-transferase, interacts with and decreases the stability and activity of the HOXA1 transcription factor.
Draime A; Bridoux L; Belpaire M; Pringels T; Tys J; Rezsohazy R
Biochim Biophys Acta Gene Regul Mech; 2018 May; 1861(5):534-542. PubMed ID: 29471045
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-99a-5p alleviates atherosclerosis via regulating Homeobox A1.
Han Z; Guan Y; Liu B; Lin Y; Yan Y; Wang H; Wang H; Jing B
Life Sci; 2019 Sep; 232():116664. PubMed ID: 31325426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
